Expanded subsets of circulating CD38+T cells in B cell chronic lymphocytic leukemia [B-CLL]

被引：0
|
作者：
Bjork, RL
Mcdaniel, PR
Saven, A
Bjork, RL
机构：
[1] BioTelesis Corp, San Diego, CA USA
[2] Esoterix Oncol, San Diego, CA USA
[3] Scripps Res Inst, La Jolla, CA USA
来源：
CYTOMETRY | 2002年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [41] Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance
    Calvo, Tania
    Reina-Ortiz, Chantal
    Giraldos, David
    Gascon, Maria
    Woods, Daniel
    Asenjo, Judit
    Marco-Brualla, Joaquin
    Azaceta, Gemma
    Izquierdo, Isabel
    Palomera, Luis
    Sanchez-Martinez, Diego
    Marzo, Isabel
    Naval, Javier
    Vilches, Carlos
    Villalba, Martin
    Anel, Alberto
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [42] CD40 stimulation up-regulates costimulatory molecules on chronic b-lymphocytic leukemia (B-CLL) cells and induces efficient killing of native b-cll cells by cytolytic t-cells.
    Buhmann, R
    Nolte, A
    Westhaus, D
    Emmerich, B
    Hallek, M
    BLOOD, 1997, 90 (10) : 4124 - 4124
  • [43] T cell subsets in B cell chronic lymphocytic leukemia.
    Huh, YO
    Lee, JN
    Lerner, S
    Wierda, WG
    Swett, C
    Keating, MJ
    BLOOD, 2002, 100 (11) : 358B - 359B
  • [44] The high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia (B-CLL) is decreased by thalidomide and fludarabine treatment
    Giannopoulos, K.
    Schmitt, M.
    Wlasiuk, P.
    Chen, J.
    Bojarska-Junak, A.
    Kowal, M.
    Rolinski, J.
    Dmoszynska, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 190 - 190
  • [45] Different Pattern of CD154 and CD40 Expression On B-CLL and T Lymphocytes In Peripheral Blood, Bone Marrow and Lymph Node Microenvironment In B-Cell Chronic Lymphocytic Leukemia (B-CLL)
    Jaksic, Ozren
    Gizdic, Branimir
    Veic, Tajana Stoos
    Jaksic, Vlatka Pandzic
    Kusec, Rajko
    Pejsa, Vlatko
    Jaksic, Branimir
    BLOOD, 2010, 116 (21) : 1485 - 1485
  • [46] Prelinical Evaluation of Lyn Kinase Inhibition for the Treatment of B Cell Chronic Lymphocytic Leukemia (B-CLL).
    Velcheti, Vamsidhar
    Li, Li
    Philips, Joseph
    Fuloria, Jyotsna
    Rodwig, Francis R.
    Cole, John T.
    Samaniego, Felipe
    Prakash, Om
    BLOOD, 2009, 114 (22) : 1339 - 1339
  • [47] First high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL).
    Novak, U
    Leibundgut, EO
    Jotterand, M
    Jaggi, R
    Tichelli, A
    Hager, J
    Papp, J
    Kearsey, G
    Lathrop, M
    Tobler, A
    Fey, MF
    BLOOD, 2000, 96 (11) : 712A - 712A
  • [48] TNF family molecules in the serum of patients with B-cell chronic lymphocytic leukemia (B-CLL)
    Jablonska, E
    Kiersnowska-Rogowska, B
    Rogowski, F
    Parfienczyk, A
    Puzewska, W
    Bukin, M
    LEUKEMIA & LYMPHOMA, 2005, 46 (09) : 1307 - 1312
  • [49] B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) IN 5 YOUNG-ADULTS
    TOH, BT
    LANDAY, AL
    KNOSPE, WH
    CLINICAL RESEARCH, 1986, 34 (04): : A958 - A958
  • [50] Telomere length has prognostic impact in B-cell chronic lymphocytic leukemia (B-CLL).
    Ricca, I
    Drandi, D
    Rocci, A
    Compagno, M
    Francese, R
    Mantoan, B
    Castellino, C
    Ficara, F
    Vallet, S
    Dell'Aquila, M
    Santo, L
    Caracciolo, D
    Bergui, L
    Gallamini, A
    Bazzan, M
    Marinone, C
    Boccadoro, M
    Tarella, C
    Ladetto, M
    BLOOD, 2004, 104 (11) : 275B - 275B
12345